The results revealed that the number of CD8+ T cells was decreased in the blood of CCL5−/− group compared with that of CCL5+/+ group (Supplementary Fig. 3C), suggesting that there was an enhanced migration of CD8+ T cells into the tumor sites in CCL5−/− mice. The gene discussed is CD8A; the disease is neoplasm.